Drug Information

Drug General Information
Drug ID
D09MTC
Former ID
DIB007497
Drug Name
ADL-5945
Synonyms
OpRA III
Indication Constipation [ICD9: 564; ICD10:K59.0] Discontinued in Phase 2 [548967]
Company
Eli Lilly & Co
Target and Pathway
Target(s) Mu-type opioid receptor Target Info Antagonist [531510]
KEGG Pathway Neuroactive ligand-receptor interaction
Estrogen signaling pathway
Morphine addiction
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Enkephalin release
Pathway Interaction Database IL4-mediated signaling events
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways TCR Signaling Pathway
GPCRs, Class A Rhodopsin-like
Peptide GPCRs
Opioid Signalling
GPCR ligand binding
GPCR downstream signaling
References
Ref 548967Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030930)
Ref 531510Novel opioid antagonists for opioid-induced bowel dysfunction. Expert Opin Investig Drugs. 2011 Aug;20(8):1047-56.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.